Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A simple stretch during dialysis might soothe restless legs

NCT ID NCT07748065

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests whether a physical therapy technique called Muscle Energy Technique (MET) can reduce restless legs syndrome in people with end-stage kidney disease who are on hemodialysis. Participants receive either routine dialysis care or the same care plus MET during their dialysis sessions, three times a week for eight weeks. Researchers will measure changes in restless legs severity, sleep quality, muscle strength, blood pressure, and oxygen levels to see if adding MET provides extra benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Muscle Energy Technique (MET), a physical therapy procedure performed during dialysis sessions
What this could lead to
If effective, this simple, drug-free technique could offer a way to ease restless legs and improve sleep and strength in people on dialysis.
What could go wrong
This is a small, early-stage trial, so results may not apply broadly. The technique may not reduce symptoms, and benefits could be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Aug 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 55 to 65 years. * Diagnosed with end-stage renal disease (ESRD). * Receiving maintenance hemodialysis three times per week for at least one year, with each session lasting approximately 4 hours. * Diagnosed with restless legs syndrome using the International Restless Legs Syndrome Study Group (IRLSSG) Rating Scale. * Under regular medical care. * Body mass index (BMI) between 25.8 and 28.8 kg/m². * Men and women were eligible. Exclusion Criteria: * Resting systolic blood pressure \>200 mmHg and/or diastolic blood pressure \>120 mmHg. * Neurological disorders (e.g., stroke or head injury) associated with chronic pain. * Uncontrolled pulmonary disease. * Cognitive impairment or mental disorders that prevented participation in the intervention. * Missed more than two weeks of the intervention program or withdrew from the study. * Severe obesity. * Malignant disease. * Unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, acute pericarditis, or myocarditis. * Hearing impairment. * Receiving muscle relaxant medications.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End-stage renal disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure restless legs syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

End-stage renal disease Restless legs syndrome (RLS)

Contacts and locations

Locations

  • Tala Central Hospital

    Tala, Menoufia Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.